Email Updates

You are here

The ECHO Trial: Preparing for Action

June 7, 2019

<em>Px Pulse</em> Logo

The ECHO trial (Evidence for Contraceptive options in HIV Outcomes) looked at three highly effective contraceptive methods to determine if one carried a higher risk of acquiring HIV compared to the others. Mixed data from previous observational studies had raised questions about one particularly popular method, known as DMPA-IM. The results of ECHO are due out in the coming weeks, with stakeholders from both the HIV and sexual and reproductive health fields watching closely.

In this episode of Px Pulse, AVAC spoke with two leaders from the ECHO trial team, Dr. Jared Baeten and Dr. Helen Rees, to understand what the trial can and cannot tell us. And you’ll hear leading women’s advocates from several countries where the ECHO trial took place share their demands. Carry what you learn forward as the ECHO trial raises the volume on an urgent conversation — how to empower African women around their sexual and reproductive health.

Listen to the full podcast (23:40).


Additional Resources

Background on the ECHO study
Background on HC use and HIV